Diantha Duvall
Director of Finance/CFO chez CURIS, INC.
Fortune : 7 000 $ au 31/03/2024
Profil
Diantha Duvall is currently the Director at BioTheryX, Inc. since 2021 and the CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Previously, she worked as the Executive Director at Merck & Co., Inc. from 2009 to 2015, the Global Commercial Controller at Biogen, Inc. from 2016 to 2017, the Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022, and the Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019.
Ms. Duvall completed her undergraduate degree at Colby College and holds a graduate degree and an MBA from Northeastern University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURIS, INC.
0,01% | 25/03/2024 | 644 ( 0,01% ) | 7 000 $ | 31/03/2024 |
Postes actifs de Diantha Duvall
| Sociétés | Poste | Début |
|---|---|---|
| CURIS, INC. | Director of Finance/CFO | 05/08/2022 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director/Board Member | 09/08/2021 |
Anciens postes connus de Diantha Duvall
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 01/07/2022 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 01/01/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2017 |
| MERCK & CO., INC. | Director/Board Member | 01/01/2015 |
Formation de Diantha Duvall
| Colby College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| CURIS, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
